PTSM: Pharmaceutical Technology Sourcing and Management
GENCO, a FedEx Company, introduces a multi-tenant warehouse model in Milton, Ontario, and Memphis, Tennessee.
GENCO, a FedEx Company, has expanded its network with the introduction of a multi-tenant warehousing solution for healthcare customers in the United States and Canada, the company announced on Oct. 25, 2016. With the expansion, GENCO offers small and medium-sized manufacturers supply-chain solutions traditionally used by only large-scale customers in dedicated facilities.
This solution allows multiple manufacturers to operate alongside each other in one warehouse, using a designated space equipped with a shared technology platform. The solution benefits customers by increasing access to flexible cost structures, rapid scalability, and the GENCO and FedEx service portfolios. The multi-tenant approach helps manage regulatory compliance and alleviates fixed operating costs.
The multi-tenant facilities are located in Memphis, Tennessee, and Milton, Ontario, Canada, and they comprise 1,100,000 ft2 and 400,000 ft2 of space, respectively. The warehouses have support to store and distribute virtually all classes of healthcare products and include advanced warehouse, labor, and quality management technology. The facilities will also be properly licensed to support kitting and relabeling activities. The Memphis facility is positioned near the global FedEx Super Hub, and the Milton facility is in close proximity to the FedEx Express Canada hub located at Toronto’s Pearson International Airport.
“Due to increasing margin pressures within the healthcare industry, manufacturers of medical devices, diagnostic testing, and pharmaceuticals are hyper-focused on streamlining their supply chain and enhancing overall efficiency in order to stay competitive,” said Kevin J. McPherson, vice-president of Healthcare at GENCO, in the press release. “In today’s healthcare environment of rapid change, manufacturers need a solution that allows their supply chain costs to adapt to changing business needs.”
Source: GENCO
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.